BIOLASE, Inc. the global leader in dental lasers, announced today that recent data published in two journals, the International Journal of Periodontics & Restorative Dentistry and Lasers in Medical Science, demonstrates BIOLASE's Waterlase Er,Cr:YSGG laser technology can be beneficial for the treatment of peri-implantitis in patients suffering from the inflammatory disease.

In a first-of-its-kind human histological study led by Dr. Myron Nevins, researchers reported that the Er,Cr:YSGG laser has a positive role in debridement of a titanium implant surface to facilitate subsequent regenerative treatment. The findings suggest the value that BIOLASE's Waterlase technology has for dentists who are seeking devices that can assist in periodontal treatments.

Similarly, data published in Lasers in Medical Science by Drs. David M. Kim and Dr. Chia-Yu (Jennifer) Chen, displays that the Er,Cr:YSGG laser effectively decreases bacteria from zirconia discs. Furthermore, fibroblast attachments on the surfaces of the zirconia discs show more adherence when treated with Er,Cr:YSGG laser technology. There is a significant increase in the number of zirconia dental implants being placed throughout the world.

"Although studies can vary, data suggests as much as 56% of people with dental implants may have peri-implantitis," said John Beaver, CEO of BIOLASE. "Unfortunately, treatment methods for peri-implantitis can be painful, costly, ineffective and unpredictable. The findings of these recent studies confirm that Waterlase laser technology can be a more viable treatment option than alternative methods. We look forward to continuing to provide dentists with minimally invasive treatment options through advanced laser technology that benefits their patients."

To learn more about BIOLASE's Waterlase laser and other available laser technologies, visit biolase.com.

About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

Visitors to Dentalpalooza can visit Henry Schein’s tent (#98) to explore a variety of intraoral scanners, with Henry Schein representatives available to answer questions and offer demonstrations. Attendees can also register for the Henry Schein sponsored "Exceed with CEREC: 101 - The Basics" course featuring Dr. Bob Conte.

For more information, please visit https://pages.henryscheindigital.com/dentalpalooza-2021.

Benco Dental, the nation's largest independent distributor of oral healthcare technology and supplies, has finalized a definitive agreement to purchase the assets of ADI Mobile Health.

The acquisition brings together ADI's proven skill at manufacturing uncompromising mobile clinics with Benco's industry-leading, in-house interior design and equipment planning capabilities to open the door for a complete reimagination of what's possible in mobile clinics. In addition, ADI products will now also be available through Benco's sales team of over 400 associates across the United States.

Both parties expect to complete the transaction during the coming weeks. Benco will operate ADI as one of its wholly-owned subsidiaries, and the transition will be seamless for ADI customers as its employees and systems will carry over. ADI will continue to be headquartered at its current location in Tualatin, Oregon.

Since 1984, ADI Mobile Health has manufactured the finest custom-crafted mobile dental/medical health clinic vehicles for customers around the world. Their patented generator systems deliver unmatched levels of consistent power production at low vibration and decibel levels that enable a relaxing experience for patients and practitioners alike. Founded by Tim Kitch, ADI’s singular focus has helped the company carve out a prominent position in a rapidly growing segment as patients demand greater convenience and access to care.

Benco Dental, headquartered in Northeastern Pennsylvania, is America's largest family-owned dental distributor, offering a complete portfolio of technology, supplies, equipment, consulting and other services from coast to coast. As the first dental distributor to offer dental practice design and space planning in 1978, Benco has established a position of industry leadership. This grew substantially with the introduction of CenterPoint design and equipment facilities beginning in 2010, which changed the way customers try and buy equipment while simultaneously planning their practice designs. Today, Benco Dental operates CenterPoint locations in California, Texas and Pennsylvania, and introduced the CenterPoint Virtual Experience during 2020 in response to Covid-19.

"Benco Dental is committed to driving dentistry forward through innovation and world-class customer experiences. Combining the proven strengths of ADI and Benco is an exciting first step toward becoming the undisputed leader in the mobile clinic space," said Chuck Cohen, Benco Dental Managing Director. "We're thrilled to carry on Tim Kitch's legacy as a passionate entrepreneur and proud to have ADI's entire team join Benco's family of companies. As dentists and patients seek more convenient care delivery, we believe there has never been a better time to enter this business."

About Benco Dental

Benco Dental is Driving Dentistry Forward® with innovative solutions and our caring family culture. Our industry firsts include Painless® electronic ordering, automated supply management, BluChip® customer loyalty rewards, CenterPoint design/equipment superstores and OneVisitTM open architecture CAD/CAM. Independent since 1930, our over 1,500 dedicated associates serve customers at locations nationwide including 400+ sales representatives and 300+ factory-trained service technicians. Benco Dental is one of Fortune's Best Workplaces in Health Care and Biopharma and among Pennsylvania Best Places to Work® for 12 of 15 prior years. 

Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced the new iTero Workflow 2.0 software release with advanced features that provide enhanced intraoral image sharpness for clearer hard and soft tissue details to aid in treatment diagnosis, while also driving practice efficiency, patient engagement, and a more seamless end-to-end digital treatment experience for doctors and their patients.

“Align’s commitment to innovation in digital orthodontics and restorative dentistry reflects our $250 million annual investment in technology to develop products and services that provide doctors and their patients with a great treatment outcome and seamless experience through the Align digital platform,” said Yuval Shaked, Align SVP and MD of the iTero systems and services business. “Our new iTero Workflow 2.0 software features were developed to simplify and streamline a doctor’s daily routine and increase practice efficiency. From a faster, all-in-one scan with enhanced visualization capabilities to improved patient communication, including the ability to capture, annotate and then share Invisalign simulations or restorative treatment plans digitally, these new features provide doctors with the ability for better clinical diagnosis and help patients better understand their oral health conditions and the proposed treatment options.”

The newly released iTero Workflow 2.0 software features include:

Faster scanning: Enables a faster and smoother all-in-one scan for maximum efficiency with 20% less waiting for processing time on the iTero Element Plus Series scanners1 and 50% faster movement and 25% faster rotation during scanning2 for efficient daily use and ease of learning on all iTero Element scanners.

Improved visualization: The integrated 3D intraoral camera included in the iTero Element 5D Plus imaging system provides enhanced sharpness and improved image quality powered by advanced AI capabilities to deliver clearer soft and hard tissue details to support diagnosis3. In addition, the enhanced capabilities allow clinics to efficiently use intraoral scan images in place of traditional intraoral photos as they can capture multiple intraoral images at different angles automatically with one scan.

Next level patient communication tools: The new Snapshot tool and iTero Scan Report provide doctors and their staff with the ability to capture information such as Invisalign Outcome Simulator projections and share it digitally with their patients, allowing patients to make more confident decisions – in the dental chair or at home – which may lead to higher treatment acceptance.

“I am already experiencing meaningful differences with the new iTero software features and have seen significantly reduced scan times,” said Dr. Olivier Boujenah, a dentist in France who participated in the limited market release. “The intraoral images are much sharper, and my patients are impressed by the details and clarity, which leads them to ask more questions about treatment options. Being able to send digital files with patients when they leave the office through the iTero Scan Report keeps our conversation going even after they are home and I already see this capability helping with patient acceptance.”

iTero Workflow 2.0 software features are being rolled out regionally and are expected to be available in all markets where the iTero Element Plus imaging systems are available by the end of Q2’21. Software features will vary by scanner. Discover more at https://bit.ly/2ROw0fD.

New iTero Element 5D imaging system auto-upload functionality

The company also announced that new iTero Element 5D imaging system auto-upload of intraoral photos for Invisalign case submissions will be available in the third quarter of 2021. This new functionality will eliminate steps and streamline Invisalign case submissions with intraoral color scan images that can be used in place of traditional intraoral photos.

The iTero Element 5D imaging system wands are designed with advanced technology, including an intraoral camera, that enables the doctor to scan, capture and auto convert the scan into 2D color photos. This enhanced capability provides doctors the option to automatically populate the five required images in the prescription form in the Invisalign Doctor Site (IDS) with 2D color scan photos. Currently, the Invisalign prescription form requires at least five intraoral photos upon submission, taken with Invisalign Photo Uploader (IPU) or a digital camera. This new auto upload functionality will be available in all markets where the iTero Element 5D imaging systems are sold.

“I am excited to hear about the new iTero Element 5D auto-upload feature,” said Dr. Heather Stone Hopkins, an orthodontist in Lexington, South Carolina and an Align North America faculty member. “Digital technology such as the iTero scanner has been a game changer for my practice. In addition to eliminating goopy PVS impressions, the iTero Element 5D also simultaneously records 3D, intraoral color and NIRI images — eliminating the need for multiple devices. With this new iTero Element 5D feature, intraoral color scan images can be used in place of the required intraoral photos for Invisalign case submissions, and without the discomfort of cheek retractors for a better patient experience. Automatic intraoral image capture and auto-upload to the Invisalign Doctor Site is an enhancement that will drastically improve our workflow, saving my team members and patients invaluable time for our Invisalign case submissions.”

Data on file, as of December 22, 2020.

Compared with previous software versions. Data on file at Align Technology, as of March 29, 2021.

Only available on iTero Element 5D Plus imaging systems (full and Lite software configurations).

*iTero Element 5D Imaging systems include iTero Element 5D and iTero Element 5D Plus series scanners.

About Align Technology, Inc.

Align Technology designs, manufactures and offers the Invisalign system, the most advanced clear aligner system in the world, iTero intraoral scanners and services, and exocad CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 200 thousand doctor customers and is key to accessing Align’s 500 million consumer market opportunity worldwide. Align has helped doctors treat over 10.2 million patients with the Invisalign system and is driving the evolution in digital dentistry through the Align Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit https://www.exocad.com.

Forward-Looking Statements

This news release contains forward-looking statements, including quotations and expectations regarding product and services development and spending, the capabilities of new features and functionalities, and our expectations for our new products, features, and accessories and their availability. Forward-looking statements contained in this news release relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements are only predictions and are subject to risks, uncertainties, and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statement.

Factors that might cause such a difference include, but are not limited to:

the impact of the COVID-19 pandemic on the health and safety of our employees, customers, patients, and our suppliers, as well as the physical and economic impacts of the various recommendations, orders, and protocols issued by local and national governmental agencies in light of continual evolution of the pandemic, including any periodic reimplementation of preventative measures in various global locations;

unexpected or rapid changes in the growth or decline of our domestic and/or international markets;

increasing competition from existing and new competitors;

rapidly evolving and groundbreaking advances that fundamentally alter the dental industry or the way new and existing customers market and

provide products and services to consumers;

the ability to protect our intellectual property rights;

continued compliance with regulatory requirements;

declines in, or the slowing of the growth of, sales of our intra-oral scanners domestically and/or internationally and the impact either would have on the adoption of Invisalign products;

the willingness and ability of our customers to maintain and/or increase product utilization in sufficient numbers;

the possibility that the development and release of new products or enhancements to existing products do not proceed in accordance with the anticipated timeline or may themselves contain bugs or errors requiring remediation and that the market for the sale of these new or enhanced products may not develop as expected;

the risks relating to our ability to sustain or increase profitability or revenue growth in future periods (or minimize declines) while controlling expenses; and the loss of key personnel or work stoppages.

The foregoing and other risks are detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including, but not limited to, our Annual Report on Form 10-K for the year ended December 31, 2020, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2021. Align undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

The American Association of Oral and Maxillofacial Surgeons (AAOMS) has named Karin Wittich, CAE, as its executive director, effective June 1. 

She has served as AAOMS Associate Executive Director of Practice Management and Governmental Affairs since 2004. The AAOMS Executive Director Search Committee unanimously approved her appointment in March after interviewing five high-profile healthcare executive candidates. She also will serve as executive director of the OMS Foundation. 

Wittich replaces Scott Farrell, MBA, CPA, who is retiring after five years as executive director. Previously, he was AAOMS Chief Financial Officer and Associate Executive Director of Business and Operations for 18 years.

“With her impressive experience at AAOMS and past history working in oral and maxillofacial surgery (OMS) offices, Karin brings extensive knowledge to the position of executive director,” said AAOMS President B.D. Tiner, DDS, MD, FACS. “She maintains productive, collaborative relationships with allied organizations, dental specialty organizations and other key strategic partners and has been heavily involved in our advocacy efforts, helping ensure issues important to the specialty are discussed and signed into law. We look forward to her accomplishments as AAOMS Executive Director.” 

Wittich, of Elgin, Ill., joined AAOMS as Manager of the Practice Management department in 1999. Her team’s major projects have included implementation of online learning and webinars, development of the OMS Quality Outcomes Registry (OMSQOR®) to collect data from OMS practices and the Dental Anesthesia Assistant National Certification Examination (DAANCE) program as well as increasing the number of practice management and coding educational offerings. In addition, she has managed all state and federal government affairs activities, including Day on the Hill, and has served as Secretary to OMSPAC. Involved with the OMS specialty for more than 30 years, she received AAOMS honorary fellowship in 2017.

Previous to AAOMS, Wittich was a practice administrator at two OMS offices in suburbs of Chicago, where she was responsible for all operational and accounting activities. She became a Certified Association Executive in 2013.

“I am proud to begin the next chapter of my professional career serving as the executive director of AAOMS and, alongside my colleagues and the members we serve, will continue to advance the mission of the organization,” Wittich said. “I am grateful to my mentors and friends who have inspired and supported me over the last 30-plus years.” 

The experts in face, mouth and jaw surgery® — The American Association of Oral and Maxillofacial Surgeons (AAOMS) is the professional organization representing more than 11,000 oral and maxillofacial surgeons, OMS residents and OMS professional staff in the United States. AAOMS supports its fellows’ and members’ ability to practice their specialty through education, research and advocacy. AAOMS fellows and members comply with rigorous continuing education requirements and submit to periodic office anesthesia evaluations. For additional information about oral and maxillofacial surgery, visit the AAOMS websites at AAOMS.org and MyOMS.org.

 Overjet, the global leader in dental artificial intelligence, today announced that it received FDA 510(k) clearance for its Overjet Dental AssistTM product. This Software as a Medical Device product applies artificial intelligence in real-time to aid dentists and hygienists. The clearance by the FDA will enable Overjet to market and sell the AI product directly to dental practices. The software supports dental professionals in measuring mesial and distal bone levels in bitewing and periapical radiographs for the diagnosis and treatment planning of periodontal disease. The condition affects an estimated 46 percent of U.S. adults, including 8.9 percent who have severe periodontitis. Left untreated, periodontitis can lead to tooth loss and painful chewing.

"Overjet's Dental Assist clearance by the FDA is a landmark moment for dental AI," said Dr. Wardah Inam, PhD, CEO and co-founder of Overjet. "All clinicians can now have at their fingertips highly accurate software to detect and measure serious dental disease and clear AI visualizations to communicate with patients. This is big for dentistry and moving toward evidence-based, patient-centric care."

In clinical performance testing, Overjet Dental AssistTM demonstrated automated measurement capabilities comparable to a team of highly skilled dentists. Overjet had three experienced dentists independently measure bone levels on dental radiographs using a measuring tool. These measurements were then further adjudicated by an oral radiologist to establish an official consensus ground truth. Overjet's AI-powered Dental Assist measurements were then compared against this dentist consensus and had an average difference of only 0.3mm.

"We're seeing dental AI software perform at the level of a team of trained dentists with accuracy closer than the width of a needle," said Dr. Chris Balaban, DMD, Clinical Director for Overjet. "These tools unlock the ability to track the progression of disease over time for each tooth and make the case for evidence-based treatment, supported by unbiased software and clear visuals for patients."

Three-year-old Overjet was founded by a team of PhDs and dentists from MIT and Harvard. They built the company around the mission of improving oral healthcare for all. To date, the company has raised over $10.5 million in venture funding and built artificial intelligence models to detect a variety of dental conditions such as cavities, gum disease, tartar and impacted teeth. Overjet's software is already in daily use by multiple large dental insurance companies to automate and improve the accuracy of dental claims review. The company has numerous partnerships with research institutions, dental support organizations and large dental practices.

About Overjet

Overjet is the global leader in dental artificial intelligence, helping both payers and providers improve patient care. Overjet's in-practice AI software bolts on to existing practice management software and is designed to help dentists deliver high-quality care, automate administrative tasks, and identify areas for growth. For more information, follow Overjet at www.overjet.ai and on LinkedIn and Twitter.

Vyne Dental®, a leading provider of revenue cycle, claims management and electronic health information exchange for all-sized dental practices, announces that it has acquired Operability, LLC, and its OperaDDS patient communications and engagement platform.

With more than 14,000 combined users in the United States, OperaDDS facilitates end-to-end transfer of information between dental practices, provider, and patients via automated email, two-way text messaging, custom paperless forms, and encrypted email services.

OperaDDS automatically texts or emails dental patients with appointment reminders, new or expired electronic forms, and other important communications from their dental provider. In addition to texting or emailing customized, paperless forms for completion, OperaDDS allows patients to quickly complete these forms on the practice’s website, or in-practice via tablet or kiosk.

Dr. Bryan Laskin, the founder of Minneapolis-based Operability, LLC, is joining Vyne Dental as a strategic advisor to ensure OperaDDS’ continued success as it is paired with Vyne Dental solutions, including Vyne Trellis.

Vyne Dental recently released Vyne Trellis(™), a comprehensive, web-based dental billing platform designed to help dental practices improve and manage their revenue cycles, exchange encrypted health information, and determine a patient’s insurance eligibility and benefit coverage levels in real-time.

Pairing Vyne Trellis with OperaDDS creates a unique integration, in the dental space, between the traditional revenue cycle and patient engagement workflows, with the goal of elevating the dental practice-dental patient relationship through robust patient interaction and engagement.

“For the past year, Vyne’s Dental’s mission has been to become a leading provider of fully automated revenue cycle management solutions in dentistry,” said Steve Roberts, president of Vyne Dental. “With the previous acquisitions of Renaissance Electronic Services, LLC, Tesia Clearinghouse, LLC, DSO Data, and now this exciting, new technology, we are one step closer to accomplishing this goal.”

Launched in 2011, OperaDDS has focused on elevating the dental industry by embracing technology and putting patients first.

“I’m passionate about helping doctors grow their practices and improve their patient satisfaction by embracing technology,” said Dr. Laskin, a practicing dentist, technologist, and entrepreneur. “OperaDDS’ innovations are being used by thousands of dental practices across the country, and through this integration, I’m confident that we’ll be able to tackle many more of dentistry’s most significant patient engagement and revenue cycle challenges.”

The acquisition of Operability, LLC further establishes Vyne Dental as the industry leader in end-to-end information exchange and communication management solutions for healthcare, Roberts said. Vyne Dental currently helps more than 74,000 dental practices manage their revenue cycles, send encrypted communications, and position their practices to thrive.

For more information on Vyne Dental, visit www.vynedental.com/.

For more information about OperaDDS, visit https://operadds.com/.

About Vyne Dental

Vyne Dental is part of the Vyne family of industry-leading information exchange and communication management solutions for healthcare. Vyne Dental helps clients manage their revenue cycle, send encrypted communications, and position their practices to thrive. Vyne Dental solutions deliver greater operational efficiency, financial performance, and improved data protection to more than 73,000 dental practice offices across the US and also partners with more than 750 dental plans and payers for the electronic delivery of claim documentation.

Vyne Dental is continuously growing and always striving to advance the dental industry by providing innovative solutions to improve workflow, decrease administrative costs, and improve reimbursements.

For more information, visit vynedental.com.

Glidewell has launched the BruxZir® Zirconia Shade Guide, the world's first shade-taking system designed specifically for BruxZir Zirconia dental restorations. 

Since the introduction of BruxZir Zirconia in 2009, dentists have relied on traditional shade guides to select shades for zirconia restorations. However, traditional shade guides are typically made from porcelain or acrylic, both materials that have optical characteristics that differ from those of zirconia. These optical dissimilarities increase the risk of metamerism, or incorrectly perceiving a color match, and can contribute to diminished esthetic results for patients.

To alleviate these concerns, the team at Glidewell developed the BruxZir Zirconia Shade Guide, a system informed by the company's experience in assisting dentists worldwide in the delivery of more than 23 million BruxZir restorations. The BruxZir Shade Guide is set to empower clinicians to determine shades for BruxZir crowns & bridges with increased precision, simplicity, and speed.

Evolving beyond traditional shade guides, the shade tabs included with the BruxZir Shade Guide are created from genuine BruxZir Zirconia and feature the translucency characteristics of the BruxZir Esthetic formulation. This composition ensures an optimal match between the shade tab and the definitive BruxZir restoration.

The shade system is made up of eight tabs. Seven of the tabs, Z2 through Z8, are equivalent to the most popular shades from the VITA® shade system. The final tab, Z1, is bleach-colored to ensure a more complete selection lineup. Moreover, each tab features a glazed and unglazed side, enabling dentists to assess both final and stump shades with a single tool. 

"I'm confident that the new BruxZir Shade Guide will enhance the quality of restorative work for dentists and delight their patients, or I wouldn't have put my name on it," said Jim Glidewell, CDT, President and CEO of Glidewell. 

To learn more about the new BruxZir Zirconia Shade Guide, visit glidewell.com or call 800-854-7256.

ClearCorrect, a Straumann Group brand and a leading manufacturer of clear aligners, announced today that it is accelerating its manufacturing turnaround time, standardizing the time from case approval to shipping to a lightning fast 10 days. The shortened turnaround time will allow ClearCorrect clinicians to quickly provide their patients with aligners and reduce the time required to begin treatment, meeting clinician needs for faster service as well as patients’ need for quicker, more confident smiles as mask mandates are lifting.

ClearCorrect continues to regionalize its manufacturing, placing its end products closer to the user. For patients in the U.S. and Canada, aligners have always been manufactured solely in Texas. U.S. production allows for rapid delivery, while also guaranteeing all products meet the highest quality benchmarks. With continued global increase in demand, ClearCorrect has expanded manufacturing sites to Brazil and Germany.

“With COVID-19 vaccinations increasing and mask mandates being lifted, many people are telling me that they can’t wait to smile again, but want that smile to be healthy and perfect,” said Jennifer Derse DDS, Founder Espire Dental. “My practices have seen a significant increase in the number of appointments for teeth straightening as people take steps to make sure their smile is ready for the post-mask world. ClearCorrect’s commitment to a rapid turnaround time helps us get patients quickly into clear aligners, so that they can remove their mask with the confidence of a healthy new smile.”

“ClearCorrect was founded by a dentist, harnessing innovation in order to equip clinicians to better meet the needs of their patients. This mandate has always been central to our vision,” said Christophe Carsault, ClearCorrect Vice President of Orthodontics, North America. “As more and more North Americans choose clear aligners, we understand the importance of rapid delivery so that they are able to quickly see results and achieve an improved smile.”

“By committing to a standard 10-day manufacturing turnaround time, ClearCorrect is raising the bar for the entire clear aligner industry and opening up new options to patients,” Carsault continued.

About ClearCorrect

ClearCorrect, a Straumann Group brand, is a leading clear aligner manufacturer that has provided best-in-class support and quality, clinically driven products for doctors since 2006. Manufactured in the U.S., its aligners are administered with doctor supervision, placing more power in the hands of those most qualified to develop safe and effective treatment plans customized to each patient’s specific needs. Today, ClearCorrect serves tens of thousands of trusted Providers around the world. To find a ClearCorrect provider near you, visit www.clearcorrect.us.

About Straumann

The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Anthogyr, ClearCorrect, Dental Wings, Medentika, Neodent, Straumann and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, biomaterials and digital solutions for use in tooth replacement and restoration or to prevent tooth loss.

Headquartered in Basel, Switzerland, the Group currently employs approx. 7680 people worldwide and its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.